Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 October 2020 | Story Thabo Kessah | Photo Supplied
Siphamandla Shabangu hopes to develop intercontinental networks during the Qatar University webinar.

“Assume you are in a leadership position, what can you do to improve the future of higher education?”
This is one of the questions Qwaqwa Campus SRC member, Siphamandla Shabangu, will be discussing during an international webinar to be hosted by Qatar University on Monday 5 October 2020. He will represent the University of the Free State, South Africa, and the African continent as a panellist to discuss the topic: Preparing for an Unpredictable Future: Global Insights from Higher Education Students. 

“Words to describe how it feels to represent not only my campus or institution, but the whole South African nation can never express this new feeling I have,” said Siphamandla. “I have never been afforded such an auspicious opportunity. This is indeed a new feeling for me, and I will do my best to turn it into a habit. I am honoured to have been selected to represent South Africa in a global academic and leadership space. I am a proud UFS ambassador and hope to one day become the face of the University of the Free State,” he added.

Tough selection process

Siphamandla revealed that the process of selection started with the Career Development office on campus. “I was selected among many greater minds on the Qwaqwa Campus. Fortunately, I further prospered among students across all three campuses of the University of the Free State, and finally became one of the best among the greats. Now, I am proud to be part of six unique panellists from different countries to unpack the impact of COVID-19 on institutions of higher learning. In fact, it is a prestigious honour to be the only African panellist – black African for that matter – in this global panel discussion,” he said.

Looking forward to the webinar

“I would very much like to acquire student lived experiences from countries outside the continent during the COVID-19 pandemic. I am also interested to know what methods of learning are sustainably applied at higher learning institutions from the perspectives of developing and highly developed countries. Moreover, I am eager to find out as to what leadership-inspired methods work best in different continents within the educational space that is gradually consumed by the Fourth Industrial Revolution. Furthermore, I am looking forward to developing international and intercontinental networks that will equip me to best explore opportunities across the globe. The academic space is dominated by intellects, visionaries, hustlers, lifelong learners, problem solvers, and even creative thinkers such as artists. However, it is within us to broaden the potential we have in life. It would be gratifying to know higher education systems from other prominent countries,” said Siphamandla.

The panel discussion will take place on Monday 5 October from 12:00 to13:00 (South African time). Other panellists are from the United Kingdom, Russia, Japan, Turkey, and Qatar. 

Siphamandla is currently serving as the SRC member responsible for Universal Access and Social Justice Council.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept